Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.6623
-0.0373 (-5.33%)
At close: Apr 14, 2026, 4:00 PM EDT
0.6424
-0.0199 (-3.00%)
Pre-market: Apr 15, 2026, 4:19 AM EDT
Impact BioMedical Market Cap
Impact BioMedical has a market cap or net worth of $71.41 million as of April 15, 2026. Its market cap has increased by 288.74% in one year.
Market Cap
71.41M
Enterprise Value
71.41M
1-Year Change
288.74%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since the IPO on September 16, 2024, Impact BioMedical's market cap has increased from $34.49M to $71.41M, an increase of 107.03%. That is a compound annual growth rate of 58.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 71.41M | 35.16% |
| Dec 31, 2025 | 52.83M | 216.73% |
| Dec 31, 2024 | 16.68M | -51.64% |
| Sep 16, 2024 | 34.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InflaRx | 77.71M |
| Pelthos Therapeutics | 77.18M |
| Estrella Immunopharma | 76.80M |
| Fractyl Health | 76.23M |
| Rani Therapeutics Holdings | 76.19M |
| iBio, Inc. | 75.65M |
| NRx Pharmaceuticals | 75.32M |
| Coeptis Therapeutics Holdings | 75.24M |